Amotio is redefining orthopaedic revision surgery by developing innovative, patient-specific solutions to remove bone cement safely and efficiently.
Over 5 million major joint replacements are performed worldwide each year, restoring mobility and quality of life. However, up to 10% will require revision surgery. Amotio is emerging with a new unique patient specific surgical approach and medical device to reduce the complexity of procedures.
Transforming Revision Surgery.
Amotio has developed patient-specific solutions that set new standards in orthopaedic revision, empowering surgeons to operate with greater accuracy and confidence.
Precision for Better Outcomes
Through advanced digital planning, Amotio’s solutions reduce surgical time, improve bone preservation, and enhance patient recovery — delivering measurable improvements in care.
Trusted by Surgeons & Expert Design Engineers
Supported by clinical expertise and rigorous engineering, Amotio's solutions are designed in collaboration with leading surgeons and research institutions worldwide.
News & Milestones
A central focus of our visit will be to connect with arthroplasty and revision surgeons, particularly those working with cemented techniques in complex joint reconstruction. Amotio is developing a patient-specific solution designed to address the ongoing challenge of safe, accurate and efficient removal of bone cement during revision surgery. We are keen to discuss current clinical workflows, unmet needs, and how personalised planning and instrumentation may support improved surgical precision, efficiency and confidence for the operating team.
Alongside clinical engagement, AAOS provides an important opportunity for Amotio to meet with experienced sales agents and distributor partners operating within the US orthopaedic market. As an early-stage company preparing for international expansion, we are seeking aligned commercial partners who share our focus on clinical value, quality systems and responsible market development.
Attending AAOS marks a defining moment for Amotio. From our foundations in the Netherlands and Wales, UK , this first step onto the US stage reflects both the strength of our progress and our ambition to contribute meaningful innovation to revision arthroplasty on a global scale.
If you are attending AAOS in March and would like to meet with the Amotio team, whether as a surgeon, clinical leader or commercial partner, we would welcome the opportunity to connect and continue the conversation.
You can find the Amotio team at Booth 746
Quality at Amotio is embedded across the entire organisation and reflected in every design decision, process, and interaction. Through this accreditation, we reaffirm our commitment to the standards and foundations upon which the company is built, strengthening our responsibility to patients, clinicians, and healthcare systems.
This achievement also serves as a foundation for continuous improvement, ensuring that our practices evolve to meet the highest levels of safety, reliability, and performance.
Follow Us on LinkedIn
Stay up to date with our latest company news, events, and insights into the future of orthopaedic revision surgery.
Our Partners & Affiliations
Backed by trusted institutions in health innovation and investment.
Ready to Shape the Future of Orthopaedic Care?
Join our mission to make advanced revision surgery safer, faster, and accessible to every patient. Connect now to review pilot results, explore partnership, or invest in Amotio’s next chapter.